Otonomy to Present at the J.P. Morgan Healthcare Conference

Back to Jobs

SAN DIEGO , Jan. 03, 2017 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that David A. Weber , Ph.D., president and chief executive

Apply Now